Neuralstem Inc.
Neuralstem, Inc. (Neuralstem) is engaged in development and commercialization of regenerative medicine treatments based on its human neuronal stem cells and its small molecule compounds. Neuralstem’s technology enables the isolation and expansion of human neural stem cells from all areas of the developing human brain and spinal cord, thus enabling the generation of physiologically relevant human neurons of all types. It has developed and patented a series of small molecule compounds. The Company is developing products using technology, including Cell Therapy and Small Molecule Pharmaceutical Compounds. The Company has a wholly owned subsidiary, Suzhou